Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132615) titled 'A prospective clinical study on the efficacy, safety and recurrence of oral isotretinoin in the treatment of moderate-to-severe acne with different doses, treatment stages and medication rhythms' on Sept. 16.
Study Type: Observational study
Study Design:
Sequential
Primary Sponsor: West China Hospital of Sichuan University
Condition:
Moderate-to-severe vulgaris acne
Recruitment Status: Not Recruiting
Phase: 4
Date of First Enrollment: 2026-10-01
Target Sample Size: Observation group:500;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=342374
Publis...